FutureCeuticals Announces Publication of Groundbreaking Study on CognatiQ®'s Same-Day Cognitive Benefits

Contributed by: PR Newswire

Tags

FutureCeuticals-Study

More Like This

PR Newswire associated0

FutureCeuticals , Inc. (FC) and Aura Scientific Resolve Coffee Fruit Patent Dispute, Recognize FC Patent Rights, and Initiate Seamless Transition to CognatiQ®

PR Newswire associated0

FutureCeuticals Files Lawsuit Against NeuroRush Owner for Patent Infringement over Alleged Copycat Ingredient

Published Study Shows Clinically Significant Energy, Performance, and Metabolic Benefits of FutureCeuticals' Caffinity™

ACCESSWIRE logo

WholisticResearch Reveals the Best Nootropics of 2023

PR Newswire associated0

Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions

PR Newswire associated0

Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home, Multimodal Cognitive Assessment in People Living with ALS and FTD

PR Newswire associated0

Cumulus Neuroscience Announces Publication in Frontiers in Digital Health Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home Cognitive and EEG Assessment in People Living with Mild Alzheimer's Disease Dementia

Discover Equazen® comprehensive range: multiple pharmaceutical formats and sizes to support the cognitive health of infants, children and teenagers. For more info visit www.equazen.com

25 Years of Trust, Quality, and Health: SFI Health™ celebrates Equazen® milestone, the brand of food supplements developed to support cognitive needs